Pfizer has informed that it submitted the unaudited financial results for the third quarter and nine months ended December 31, 2022. The said results were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 2.45 pm and concluded at 4.30 pm. Also enclosed the Limited Review Report by its Auditors B S R & Co., LLP.
The above information is a part of company’s filings submitted to BSE.